Categories: All CategoriesCorporateProductsPipelineFinancial May 05, 2021Myriad Genetics CEO Paul J. Diaz to Present at Bank of America Securities 2021 Virtual Health Care ConferenceCorporateMay 03, 2021Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation InitiativesFinancialMay 03, 2021Myriad Genetics Signs Definitive Agreement to Sell Myriad Autoimmune’s Vectra Testing Business to LabcorpCorporateMay 03, 2021Myriad Genetics to Update Progress on Transformation Plan and Growth Initiatives, Share Long-Term Financial Outlook at 2021 Investor DayCorporateApr 28, 2021Depression Disconnect: GeneSight® Mental Health Monitor Shows Misunderstanding of Depression and TreatmentProductsApr 27, 2021Myriad Genetics to Release March 2021 Quarterly Financial Results on May 3, 2021, Host Investor Day on May 4, 2021CorporateApr 27, 2021Myriad Genetics Signs Definitive Agreement to Sell Myriad myPath® Melanoma, LLC, Laboratory to Castle BiosciencesCorporateMar 29, 2021Myriad Genetics Announces Eric Santa as Chief Growth Officer, Names New Diversity and Marketing LeadersCorporateMar 24, 2021Myriad Genetics Receives Additional Reimbursement for myChoice® Diagnostic System in JapanProductsMar 02, 2021Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing ServicesPipelineFeb 23, 2021Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation PlanFinancialFeb 18, 2021Technology and Health Leaders Join Myriad Genetics, Advance in Senior Roles to Drive Key Enterprise Functions, Transformation and Growth InitiativesCorporateFeb 16, 2021Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021FinancialFeb 12, 2021New Study from Leading University of Utah Radiation Oncologist Validates Ability of Myriad Genetics’ Prolaris® test to Guide Treatment for Prostate CancerPipelineFeb 11, 2021Myriad Genetics to Participate in Multiple Upcoming Health and Technology ConferencesCorporate Next page
